Carlos Fraga

[Carlos Fraga @cmfraga]

10th Brazilian Symposium on Medicinal Chemistry (BrazMedChem_2022) https://t.co/V0Mqb8AzSW #mdpipharmaceuticals via @MDPIOpenAccess

[Carlos Fraga @cmfraga]

Good news! My article received enough citations to be a #topcitedarticle in its journal.

[Carlos Fraga @cmfraga]

@ChemMedChem @UniboMagazine @mlbolognesi @cla_albertini @PedrodeSena6 Congrats!!!

[Carlos Fraga @cmfraga]

Design, Synthesis and Pharmacological Evaluation of  First‐in‐Class Multitarget N‐Acylhydrazone Derivatives as Selective HDAC6/8 and PI3Kα Inhibitors https://t.co/n8MaKb0tFY

[Carlos Fraga @cmfraga]

@mlbolognesi @b2alzd2 @hemattos @ManssourFraga @UniboMagazine I am grateful for the magnificent experience. These were unforgettable days in Bologna!! Thank you Maria Laura.

[Carlos Fraga @cmfraga]

Yesterday was my last class to students from the course of CHEMISTRY AND PHARMACEUTICAL TECHNOLOGY of University of Bologna. It was one of the best experiences of my life! I would like to thank Professor Maria Laura Bolognesi for the great opportunity.

[Carlos Fraga @cmfraga]

Yesterday was my last class to students from the course of CHEMISTRY AND PHARMACEUTICAL TECHNOLOGY of University of Bologna. It was one of the best experiences of my life! I would like to thank Professor Maria Laura Bolognesi for the great opportunity.

[Pharmaceuticals MDPI @Pharmaceut_MDPI]

#Duvelisib: A 2018 Novel #FDA -Approved Small Molecule Inhibiting Phosphoinositide 3-#Kinases
Free to read: https://t.co/jSbhFZu3C3